ARRAY Technologies Confirms Compatibility with 2000-Volt Solar Projects
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street rises with investors rotating into healthcare and value stocks
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.37 +0.11 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.26 | 52 Week High | $7.27 | |||
| Open | $3.21 | 52 Week Low | $2.39 | |||
| Day High | $3.40 | P/E | N/A | |||
| Day Low | $3.20 | EPS | $-0.61 | |||
| Volume | 2,854,065 | |||||
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.37 +0.11 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.26 | 52 Week High | $7.27 | |||
| Open | $3.21 | 52 Week Low | $2.39 | |||
| Day High | $3.40 | P/E | N/A | |||
| Day Low | $3.20 | EPS | $-0.61 | |||
| Volume | 2,854,065 | |||||
